Correspondence
NUTEX HEALTH INC.
6030 S. Rice, Suite C
Houston, TX 77081
VIA EDGAR
April 29, 2025
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3561
| Re: | Nutex Health Inc. Registration Statement on Form S-3 File No. 333-286554 |
Ladies and Gentlemen:
On behalf of Nutex Health Inc., and pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned hereby requests that the effective date of the above referenced Registration Statement on Form S-3 be accelerated to 4:00 p.m., Washington, D.C. time, on Thursday, May 1, 2025, or as soon as practicable thereafter.
Thank you for your assistance in this matter. If you need any additional information, please contact Gislar Donnenberg of Troutman Pepper Locke LLP at (713) 226-1351.
| Very truly yours, | ||
| Nutex Health Inc. | ||
| By: | /s/ Elisa Luqman | |
| Name: | Elisa Luqman | |
| Title: | Chief Legal Officer (SEC) | |